PDF
(Download)
|
- Hibiscus (Hibiscus sabdariffa, Malvaceae)
- Blood Pressure
- Hypertension
|
Date:
06-15-2019 | HC# 091941-626
|
Re: Hibiscus Tea Reduces Blood Pressure in Mild Hypertension
Jalalyazdi M, Ramezani J, Izadi-Moud A,
Madani-Sani F, Shahlari S, Ghiasi SS. Effect of Hibiscus sabdariffa on blood pressure in patients with stage 1
hypertension. J Adv Pharm Technol Res. July-September 2019;10(3):107-111. doi: 10.4103/japtr.JAPTR_402_18.
Hypertension is a risk factor for ischemic
heart and cerebrovascular disease and chronic kidney disease, among others.
Global prevalence is estimated at 31.1% of adults, with higher rates in low-
and middle-income countries. In Iran, 26.6% of the population has high blood
pressure (BP). In 2017, 45.6% of US adults had high BP; 36.2% were prescribed
antihypertensive drugs. Many classes of drugs are used to control BP, but all
have drawbacks in cost, availability, efficacy, and/or adverse effects (AEs).
In developing nations, insufficient awareness and treatment make managing
hypertension a challenge. Traditional herbal medicines and common foods may
play a role in BP management. Garlic (Allium sativum, Amaryllidaceae)
bulb, onion (A.
cepa) bulb, green and black tea (Camellia sinensis, Theaceae) leaves,
and hibiscus (Hibiscus
sabdariffa, Malvaceae) flowers, all used traditionally to control BP,
have supporting evidence for this use. Studies also report hibiscus' diuretic, antibacterial,
anticancer, antioxidant, nephro- and hepato-protective, anti-cholesterol, and
anti-diabetic effects. It contains proteins, fatty acids, carbohydrates,
flavonoids (anthocyanins), minerals, and vitamins. There is as yet insufficient
evidence of its effects in different medical conditions.
The authors conducted a randomized,
placebo-controlled clinical trial (RCT) of hibiscus in patients with mild
(stage 1) hypertension at an outpatient cardiology clinic at Imam Reza Hospital
(Mashhad, Iran). During the study period (not defined), 46 patients aged 18-70
years with systolic BP (SBP) 130-139 and diastolic BP (DBP) 80-89 mmHg were
enrolled. They were divided (neither randomization nor blinding are described)
into two groups of 23 each. The active group received nonmedical advice for lowering
BP and drank two standard cups/d of hibiscus as an infusion made with bags from
a local herb shop, each with 1.25 g hibiscus, for one month. Controls received
nonmedical advice only. This included weight loss under a nutritionist's
supervision, Dietary Approaches to Stop
Hypertension (DASH), less salt and more potassium intake, and aerobic exercise
five d/wk for 30 minutes. BP, measured at baseline and after one month, was
taken on each occasion three times over 15 minutes and the average used in
analysis. Statistical significance was defined as P<0.05, with a confidence
level of 95%.
Mean age of patients was 49.83±3.38 years;
mean body mass index (BMI), 28.74±3.50 kg/m2, with no significant
differences between groups. Among participants, 54.3% were men; the active
group, 48.0%; and control, 52.0%, a statistically insignificant difference
(P=0.77). There were no significant between-group differences in mean SBP or
DBP at baseline (P=0.18; P=0.88, respectively). Presumably, all 46 participants
completed the RCT. Compliance is not discussed.
Repeated measures of analysis of variance (ANOVA)
revealed significant time, group, and time×group effects on SBP
(P<0.001 for all). With significant SBP reductions in both groups
(P<0.05), reduction in the active group (-7.43 mmHg) was significantly
better than in control (-1.91 mmHg; P<0.001). Repeated measures of analysis
of variance (ANOVA) revealed significant time (P<0.001), group (P=0.002),
and time × group (P=0.001) effects on DBP. With
significant DBP reductions in both groups (P<0.05), reduction in the active
group (-6.70 mmHg) was significantly better than in control (-3.96 mmHg;
P<0.001). No AEs are mentioned.
Despite significantly better BP results in
the active group, credit must also be given to the weight reduction, DASH
regimen, improved salt/potassium intake ratio, and exercise program recommended
to all participants. It is unknown whether these dietary and physical
activities may have had synergistic effects with hibiscus. In considering hibiscus'
effects, its antioxidant and lipid-improving activities may be most relevant in
reducing BP in these mildly hypertensive adults. Hibiscus' anthocyanins can
reduce low-density lipoprotein oxidation and thus retard atherosclerosis. Another
hibiscus compound, not named, causes nitric oxide release from endothelial
cells, increasing kidney filtration and thus diuresis, a desirable effect of
many BP drugs. Other studies report that hibiscus lowered BP in mildly
hypertensive diabetic patients. Different therapeutic doses and the safety of
hibiscus and hibiscus extracts are reported. In one study, BP rose within few
days of stopping hibiscus therapy.
Among limitations to this study, the authors cite
small sample time, short enrollment period, restriction to just one medical
center, and "[p]oor assistance of patients." Positive beliefs about
herbal medicine, however, are mentioned as improving willingness to try herbal
over conventional drugs among some populations. Hibiscus grows profusely in
many areas of the world and could be sustainable in both cost and environmental
impact. Hibiscus could be an effective means to reducing BP in low- and higher
income nations. More studies are needed of its mechanisms and effective dosage
and duration, as well as potential interactions with other BP drugs. —Mariann Garner-Wizard
|